Morgan Stanley »

Matinas Biopharma Hldgs shares owned by Morgan Stanley

Quarter-by-quarter ownership of Matinas Biopharma Hldgs (MTNB) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Matinas Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Matinas Biopharma Hldgs held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Matinas Biopharma Hldgs by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-12-31 $72 144 0.51
2024-09-30 $1.8k 520 3.54

More positions owned by Morgan Stanley

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Morgan Stanley

Top funds holding Matinas Biopharma Hldgs

Vanguard Group
Sargent Investment Group
BlackRock
Geode Capital Management
Susquehanna International
Renaissance Technologies
State Street Corporation
UBS Group
Tower Research Capital
Bank of America Corporation
Jpmorgan Chase & Co
Advisor Group Holdings
Morgan Stanley
Wells Fargo & Company
Steward Partners Investment Advisory

View all funds holding Matinas Biopharma Hldgs